The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease

BACKGROUND There is a need for an accurate non-invasive diagnostic test for variant Creutzfeldt-Jakob disease (vCJD). We investigated the sensitivity and specificity of bilateral pulvinar high signal on magnetic resonance imaging (MRI) for the diagnosis of vCJD. METHODS MRI from patients with vCJD and controls (patients with suspected CJD) were analysed. Scans were reviewed on two separate occasions by two neuroradiologists and scored for the distribution of changes, and likely final diagnosis. Scans from vCJD cases were reassessed to reach a consensus on all abnormalities. FINDINGS We analysed 36 patients and 57 controls. vCJD patients were correctly identified based on bilateral pulvinar high signal in 29 of 36 and 32 of 36 cases on the first assessment by the two radiologists, and 32 of 36 and 31 of 36 on their second assessment. Bilateral increased pulvinar signal was identified in one of 57 and one of 57 controls on the first assessment and two of 57 and three of 57 controls on the second assessment. These reported changes in controls were graded as minimal/equivocal in six of seven patients and moderate in one (<0.5% of all control assessments). 80% of the assessments in vCJD cases were graded as moderate or substantial. On consensus review, 28 of 36 cases and none of 57 controls had prominent bilateral pulvinar signal-sensitivity 78% (95% CI 60-90%) and specificity 100% (95% CI 94-100%). Other common MRI features of vCJD were medial thalamic and periaqueductal grey matter high signal, and the notable absence of cerebral atrophy. Pulvinar high signal correlated with histological gliosis. INTERPRETATION In the appropriate clinical context the MRI identification of bilaterally increased pulvinar signal is a useful non-invasive test for the diagnosis of vCJD.

[1]  J. Wardlaw,et al.  Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease , 1996, BMJ.

[2]  N. Yoshimura,et al.  [A case of benign intracranial hypertension with bilateral reversible thalamic lesions on magnetic resonance imaging]. , 1992, Rinsho shinkeigaku = Clinical neurology.

[3]  C. Gibbs,et al.  Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. , 1998, The New England journal of medicine.

[4]  A. Giese,et al.  Phenotypic variability in fatal familial insomnia (D178N-129M) genotype , 1998, Neurology.

[5]  H. Urbach,et al.  MRI in sporadic Creutzfeldt-Jakob disease: Correlation with clinical and neuropathological data , 1998, Neuroradiology.

[6]  R. Higgo,et al.  New variant Creutzfeldt-Jakob disease: psychiatric features , 1997, The Lancet.

[7]  J. Bell,et al.  Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease , 1995, Neuroscience Letters.

[8]  E. Broussolle,et al.  New variant of Creutzfeldt-Jakob disease in a 26-year-old French man , 1996, The Lancet.

[9]  M. Rossor,et al.  Creutzfeldt-Jakob disease in a young woman , 1996, The Lancet.

[10]  R. Will,et al.  Psychiatric features of new variant Creutzfeldt-Jakob disease , 1999 .

[11]  I. Zerr,et al.  MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.

[12]  B. Steinhoff,et al.  Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. , 1996, Archives of neurology.

[13]  J. Hahn,et al.  Unusual MRI findings after status epilepticus due to cat-scratch disease. , 1994, Pediatric neurology.

[14]  M. Zeidler,et al.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests , 1997, The Lancet.

[15]  T. Erkinjuntti,et al.  MRI of the brain in neurologically healthy middle-aged and elderly individuals , 1997, Neuroradiology.

[16]  S. Cousens,et al.  Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 , 1997, BMJ.

[17]  D. Hadley,et al.  Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports , 1998, BMJ.

[18]  L. Court Transmissible Subacute Spongiform Encephalopathies : Prion Diseases , 1996 .

[19]  R. Petersen,et al.  Fatal Familial Insomnia and Familial Creutzfeldt‐Jakob Disease: Clinical, Pathological and Molecular Features , 1995, Brain pathology.

[20]  E. Bertini,et al.  Bilateral, Reversible, Selective Thalamic Involvement Demonstrated by Brain MR and Acute Severe Neurological Dysfunction with Favorable Outcome* , 1994, Neuropediatrics.

[21]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[22]  S. Smith,et al.  Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. , 1995 .

[23]  F. Tagliavini,et al.  NEUROPATHOLOGICAL CORRELATES OF MAGNETIC RESONANCE ABNORMALITIES IN EXPERIMENTAL PRION DISEASE , 1999 .

[24]  A Coulthard,et al.  Quantitative analysis of MRI signal intensity in new variant Creutzfeldt-Jakob disease. , 1999, The British journal of radiology.

[25]  O. Gefeller,et al.  Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[26]  J. Bell,et al.  A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. , 1996, Cold Spring Harbor symposia on quantitative biology.